Search This Blog

Thursday, March 18, 2010

NEW GLAUCOMA DRUG TAFLOTAN RELEASED TO INTERNATIONAL MARKETS


Clinical appraisal of tafluprost in the reduction of elevated intraocu
An elevated intraocular pressure (IOP) is one of the most important risk factors for the development of glaucoma, which causes progressive blindess.

Tafluprost was recently launched onto the market to lower eye pressure. Some studies suggest it has greater pressure-lowering effect with fewer side effects than Xalatan. It also appears to protect the optic nerve, independent of it's ability to lower pressure. If these findings are true, then we will have another weapon in our arsenal against glaucoma.

C'mon FDA!

3 comments:

  1. Thanks for the information. Glaucoma is usually deemed condition of the eye wherein sensitiveness to ocular pressure leads to retinal and optic nerve harm. It is one of the reason for eye failure. Chronic glaucoma is known as the sly robber of eyesight as one has no signs or symptoms, it is difficult to detect. There are many risk factors associated with Chronic glaucoma like age, eye irregularities, family history, hypertension, headaches etc. For more details refer glaucoma

    ReplyDelete
  2. Anonymous11:32 PM

    Hallo, I just use Taflotan for2 days. every night I use one drop. But went i wake up at the morning my eyes become reddish. It's normal? I must stop to use or continue?

    ReplyDelete
    Replies
    1. Anonymous4:11 PM

      I have the same condition, i recently start to use taflotan.
      In my case I use every other night (skip one day).
      And check your eye pressure closely.

      Delete

Leave a Comment or Question: